NXGN logo

NextGen Healthcare (NXGN) EBITDA

Annual EBITDA

$47.30 M
-$1.71 M-3.50%

March 31, 2023

Summary

Performance

1-Year Change

-3.5%

3-Year Change

-12.43%

5-Year Change

+9.21%

15-Year Change

-29.62%

NXGN EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$134.15 M
NXGN annual EBITDA is currently -64.74% below its historical high of $134.15 million

3-Year Low

$47.30 M
NXGN annual EBITDA is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Mar 31, 2023
NXGN previous annual earnings announcement was published on Mar 31, 2023

Next Annual Earnings Report Date

N/A
NXGN next annual earnings announcement has not yet been scheduled

OtherNXGNprofitabilitymetrics:

Annual Revenue

$653.17 M
NXGN annual revenue is $653.17 million

Annual Net Income

-$2.65 M
NXGN annual net profit is -$2.65 million

Annual EBIT

$10.60 M
NXGN annual earnings before interest & taxes is $10.60 million

Annual EPS

-$0.04
NXGN annual earnings per share is -$0.04

Quarterly EBITDA

$19.32 M
-$1.76 M-8.36%

September 30, 2023

Summary

Performance

3-Month Change

-8.36%

1-Year Change

-32.11%

3-Year Change

-17.1%

5-Year Change

-26.83%

NXGN Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$37.12 M
NXGN quarterly EBITDA is currently -47.96% below its historical high of $37.12 million

3-Year Low

-$11.50 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2023
NXGN previous earnings announcement was published on Sep 30, 2023

Next Quarterly Earnings Report Date

N/A
NXGN next earnings announcement has not yet been scheduled

OtherNXGNprofitabilitymetrics:

Quarterly Revenue

$176.42 M
NXGN quarterly revenue is $176.42 million

Quarterly Net Income

$5.05 M
NXGN quarterly net profit is $5.05 million

Quarterly EBIT

$10.01 M
NXGN quarterly earnings before interest & taxes is $10.01 million

Quarterly EPS

$0.07
NXGN quarterly earnings per share is $0.07

TTM EBITDA

$48.88 M
-$9.14 M-15.75%

September 30, 2023

Summary

Performance

3-Month Change

-15.75%

1-Year Change

-30.57%

3-Year Change

-19.63%

5-Year Change

-25.01%

NXGN TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$138.15 M
NXGN TTM EBITDA is currently -64.62% below its historical high of $138.15 million

3-Year Low

$44.58 M
NXGN TTM EBITDA is currently +9.65% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2023
NXGN previous earnings announcement was published on Sep 30, 2023

Next Quarterly Earnings Report Date

N/A
NXGN next earnings announcement has not yet been scheduled

OtherNXGNprofitabilitymetrics:

TTM Revenue

$695.05 M
NXGN TTM revenue is $695.05 million

TTM Net Income

-$6.21 M
NXGN TTM net profit is -$6.21 million

TTM EBIT

$11.51 M
NXGN TTM earnings before interest & taxes is $11.51 million

TTM EPS

-$0.10
NXGN TTM earnings per share is -$0.10

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

Annual EBITDA

$47.30 M
NXGN annual EBITDA is $47.30 million

Annual Net Income

-$2.65 M
NXGN annual net profit is -$2.65 million

Annual Interest Expense

$6.30 M
NXGN annual interest expense is $6.30 million

Annual Income Tax

$6.96 M
NXGN annual income tax is $6.96 million

Annual D&A

$36.69 M
NXGN annual depreciation & amortization is $36.69 million

NXGN EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-3.5%-32.1%-30.6%
3 y3 years-12.4%-17.1%-19.6%
5 y5 years+9.2%-26.8%-25.0%

NXGN EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-23.7%at low-32.1%-159.5%-31.8%-8.8%
5 y5-year-37.1%at low-32.1%-159.5%-31.8%-15.7%
alltimeall time-64.7%-105.1%-48.0%-163.5%-64.6%-118.0%

NextGen Healthcare EBITDA History

DateAnnualQuarterlyTTM
Sep 2023
-
$19.32 M(-8.4%)
$48.88 M(-15.7%)
Jun 2023
-
$21.08 M(-283.4%)
$58.02 M(+22.7%)
Mar 2023
$47.30 M(-3.5%)
-$11.50 M(-157.6%)
$47.30 M(-34.0%)
Dec 2022
-
$19.97 M(-29.8%)
$71.63 M(+1.7%)
Sep 2022
-
$28.46 M(+174.6%)
$70.40 M(+57.9%)
Jun 2022
-
$10.36 M(-19.2%)
$44.58 M(-9.0%)
Mar 2022
$49.01 M(-21.0%)
$12.83 M(-31.6%)
$49.01 M(+5.5%)
Dec 2021
-
$18.75 M(+612.6%)
$46.46 M(+12.7%)
Sep 2021
-
$2.63 M(-82.2%)
$41.22 M(-33.4%)
Jun 2021
-
$14.80 M(+43.9%)
$61.90 M(-0.2%)
Mar 2021
$62.01 M(+14.8%)
$10.28 M(-23.9%)
$62.01 M(+5.8%)
Dec 2020
-
$13.51 M(-42.0%)
$58.60 M(-3.6%)
Sep 2020
-
$23.31 M(+56.4%)
$60.82 M(+8.2%)
Jun 2020
-
$14.91 M(+116.6%)
$56.21 M(+4.1%)
Mar 2020
$54.01 M(-28.2%)
$6.88 M(-56.2%)
$54.01 M(-17.1%)
Dec 2019
-
$15.73 M(-15.9%)
$65.18 M(-1.7%)
Sep 2019
-
$18.69 M(+47.1%)
$66.30 M(-10.4%)
Jun 2019
-
$12.71 M(-29.6%)
$74.02 M(-1.6%)
Mar 2019
$75.23 M(+73.7%)
$18.05 M(+7.1%)
$75.23 M(+54.0%)
Dec 2018
-
$16.85 M(-36.2%)
$48.87 M(+5.5%)
Sep 2018
-
$26.41 M(+89.6%)
$46.34 M(+13.0%)
Jun 2018
-
$13.93 M(-267.4%)
$41.01 M(-5.3%)
Mar 2018
$43.31 M(-35.6%)
-$8.32 M(-158.1%)
$43.31 M(-35.8%)
Dec 2017
-
$14.32 M(-32.1%)
$67.46 M(-11.7%)
Sep 2017
-
$21.08 M(+30.0%)
$76.43 M(+5.1%)
Jun 2017
-
$16.22 M(+2.4%)
$72.71 M(+8.2%)
Mar 2017
$67.20 M(+79.9%)
$15.84 M(-32.0%)
$67.20 M(+71.9%)
Dec 2016
-
$23.30 M(+34.2%)
$39.09 M(+27.4%)
Sep 2016
-
$17.36 M(+62.2%)
$30.68 M(-4.9%)
Jun 2016
-
$10.71 M(-187.3%)
$32.27 M(-13.6%)
Mar 2016
$37.36 M(-42.8%)
-$12.27 M(-182.4%)
$37.36 M(-46.1%)
Dec 2015
-
$14.88 M(-21.5%)
$69.36 M(-0.7%)
Sep 2015
-
$18.95 M(+19.9%)
$69.88 M(+6.3%)
Jun 2015
-
$15.80 M(-19.9%)
$65.74 M(+0.7%)
Mar 2015
$65.27 M(+26.2%)
$19.73 M(+28.1%)
$65.27 M(+21.7%)
Dec 2014
-
$15.40 M(+4.0%)
$53.65 M(+61.6%)
Sep 2014
-
$14.81 M(-3.4%)
$33.20 M(-19.2%)
Jun 2014
-
$15.33 M(+89.1%)
$41.08 M(-20.6%)
Mar 2014
$51.74 M(-53.2%)
$8.11 M(-260.5%)
$51.74 M(-20.4%)
Dec 2013
-
-$5.05 M(-122.3%)
$65.02 M(-34.6%)
Sep 2013
-
$22.69 M(-12.7%)
$99.41 M(-7.3%)
Jun 2013
-
$26.00 M(+21.5%)
$107.25 M(-3.1%)
Mar 2013
$110.66 M(-17.5%)
$21.39 M(-27.1%)
$110.66 M(-5.8%)
Dec 2012
-
$29.34 M(-3.9%)
$117.49 M(-6.2%)
Sep 2012
-
$30.52 M(+3.8%)
$125.28 M(-4.1%)
Jun 2012
-
$29.40 M(+4.2%)
$130.66 M(-2.6%)
Mar 2012
$134.15 M(+23.4%)
$28.23 M(-24.0%)
$134.15 M(-2.9%)
Dec 2011
-
$37.12 M(+3.4%)
$138.15 M(+5.7%)
Sep 2011
-
$35.91 M(+9.2%)
$130.67 M(+9.6%)
Jun 2011
-
$32.89 M(+2.1%)
$119.21 M(+9.6%)
Mar 2011
$108.74 M(+24.9%)
$32.22 M(+8.7%)
$108.74 M(+9.0%)
Dec 2010
-
$29.65 M(+21.3%)
$99.79 M(+6.5%)
Sep 2010
-
$24.45 M(+9.0%)
$93.66 M(+3.5%)
Jun 2010
-
$22.42 M(-3.6%)
$90.52 M(+3.9%)
Mar 2010
$87.10 M(+6.9%)
$23.27 M(-1.1%)
$87.10 M(+2.7%)
Dec 2009
-
$23.52 M(+10.4%)
$84.80 M(+1.1%)
Sep 2009
-
$21.30 M(+12.1%)
$83.91 M(+3.6%)
Jun 2009
-
$19.00 M(-9.4%)
$80.99 M(-0.6%)
Mar 2009
$81.51 M(+23.7%)
$20.97 M(-7.4%)
$81.51 M(+2.8%)
Dec 2008
-
$22.63 M(+23.1%)
$79.28 M(+6.9%)
Sep 2008
-
$18.39 M(-5.8%)
$74.13 M(+3.2%)
Jun 2008
-
$19.52 M(+4.2%)
$71.82 M(+9.0%)
Mar 2008
$65.91 M(+17.6%)
$18.74 M(+7.1%)
$65.91 M(+6.7%)
Dec 2007
-
$17.49 M(+8.8%)
$61.78 M(+6.1%)
Sep 2007
-
$16.07 M(+18.1%)
$58.25 M(+3.2%)
Jun 2007
-
$13.61 M(-6.8%)
$56.43 M(+0.7%)
Mar 2007
$56.06 M(+41.4%)
$14.61 M(+4.6%)
$56.06 M(+3.3%)
Dec 2006
-
$13.96 M(-2.1%)
$54.25 M(+12.1%)
Sep 2006
-
$14.25 M(+7.6%)
$48.40 M(+9.8%)
Jun 2006
-
$13.24 M(+3.5%)
$44.09 M(+11.2%)
Mar 2006
$39.65 M(+43.8%)
$12.80 M(+58.0%)
$39.65 M(+15.5%)
Dec 2005
-
$8.10 M(-18.6%)
$34.32 M(+2.7%)
Sep 2005
-
$9.95 M(+13.1%)
$33.41 M(+10.4%)
Jun 2005
-
$8.80 M(+17.8%)
$30.27 M(+9.8%)
Mar 2005
$27.58 M(+45.4%)
$7.47 M(+3.8%)
$27.58 M(+7.4%)
Dec 2004
-
$7.20 M(+5.8%)
$25.67 M(+10.4%)
Sep 2004
-
$6.80 M(+11.4%)
$23.25 M(+11.2%)
Jun 2004
-
$6.11 M(+9.8%)
$20.91 M(+10.2%)
Mar 2004
$18.97 M
$5.56 M(+16.3%)
$18.97 M(+14.4%)
DateAnnualQuarterlyTTM
Dec 2003
-
$4.78 M(+7.2%)
$16.58 M(+9.5%)
Sep 2003
-
$4.46 M(+7.2%)
$15.14 M(+9.0%)
Jun 2003
-
$4.16 M(+31.2%)
$13.90 M(+8.3%)
Mar 2003
$12.84 M(+29.1%)
$3.17 M(-5.1%)
$12.84 M(+2.7%)
Dec 2002
-
$3.34 M(+3.9%)
$12.50 M(+6.4%)
Sep 2002
-
$3.22 M(+3.7%)
$11.74 M(+9.9%)
Jun 2002
-
$3.10 M(+9.2%)
$10.69 M(+7.5%)
Mar 2002
$9.94 M(+29.4%)
$2.84 M(+9.8%)
$9.94 M(+5.8%)
Dec 2001
-
$2.59 M(+19.6%)
$9.40 M(+5.4%)
Sep 2001
-
$2.16 M(-8.2%)
$8.92 M(+3.7%)
Jun 2001
-
$2.35 M(+2.7%)
$8.60 M(+11.9%)
Mar 2001
$7.68 M(+32.2%)
$2.29 M(+8.7%)
$7.68 M(+23.9%)
Dec 2000
-
$2.11 M(+14.3%)
$6.20 M(+15.0%)
Sep 2000
-
$1.84 M(+28.2%)
$5.39 M(+0.7%)
Jun 2000
-
$1.44 M(+77.3%)
$5.36 M(-4.7%)
Mar 2000
$5.81 M(+76.1%)
$811.00 K(-37.6%)
$5.62 M(-12.3%)
Dec 1999
-
$1.30 M(-28.1%)
$6.41 M(0.0%)
Sep 1999
-
$1.81 M(+6.3%)
$6.41 M(+18.7%)
Jun 1999
-
$1.70 M(+6.4%)
$5.40 M(+63.7%)
Mar 1999
$3.30 M(-17.5%)
$1.60 M(+23.1%)
$3.30 M(-5.7%)
Dec 1998
-
$1.30 M(+62.5%)
$3.50 M(+20.7%)
Sep 1998
-
$800.00 K(-300.0%)
$2.90 M(-3.3%)
Jun 1998
-
-$400.00 K(-122.2%)
$3.00 M(-26.8%)
Mar 1998
$4.00 M(+185.7%)
$1.80 M(+157.1%)
$4.10 M(+46.4%)
Dec 1997
-
$700.00 K(-22.2%)
$2.80 M(+33.3%)
Sep 1997
-
$900.00 K(+28.6%)
$2.10 M(+40.0%)
Jun 1997
-
$700.00 K(+40.0%)
$1.50 M(-6.3%)
Mar 1997
$1.40 M(-64.1%)
$500.00 K(>+9900.0%)
$1.60 M(-23.8%)
Dec 1996
-
$0.00(-100.0%)
$2.10 M(-32.3%)
Sep 1996
-
$300.00 K(-62.5%)
$3.10 M(-16.2%)
Jun 1996
-
$800.00 K(-20.0%)
$3.70 M(-2.6%)
Mar 1996
$3.90 M(+200.0%)
$1.00 M(0.0%)
$3.80 M(+11.8%)
Dec 1995
-
$1.00 M(+11.1%)
$3.40 M(+30.8%)
Sep 1995
-
$900.00 K(0.0%)
$2.60 M(+36.8%)
Jun 1995
-
$900.00 K(+50.0%)
$1.90 M(+35.7%)
Mar 1995
$1.30 M(0.0%)
$600.00 K(+200.0%)
$1.40 M(+16.7%)
Dec 1994
-
$200.00 K(0.0%)
$1.20 M(-33.3%)
Sep 1994
-
$200.00 K(-50.0%)
$1.80 M(+5.9%)
Jun 1994
-
$400.00 K(0.0%)
$1.70 M(+21.4%)
Mar 1994
$1.30 M(+18.2%)
$400.00 K(-50.0%)
$1.40 M(-17.6%)
Dec 1993
-
$800.00 K(+700.0%)
$1.70 M(+54.5%)
Sep 1993
-
$100.00 K(0.0%)
$1.10 M(0.0%)
Jun 1993
-
$100.00 K(-85.7%)
$1.10 M(-8.3%)
Mar 1993
$1.10 M(-650.0%)
$700.00 K(+250.0%)
$1.20 M(-114.6%)
Dec 1992
-
$200.00 K(+100.0%)
-$8.20 M(+43.9%)
Sep 1992
-
$100.00 K(-50.0%)
-$5.70 M(+62.9%)
Jun 1992
-
$200.00 K(-102.3%)
-$3.50 M(+775.0%)
Mar 1992
-$200.00 K(-50.0%)
-$8.70 M(-422.2%)
-$400.00 K(-105.1%)
Dec 1991
-
$2.70 M(+17.4%)
$7.80 M(+52.9%)
Sep 1991
-
$2.30 M(-30.3%)
$5.10 M(+82.1%)
Jun 1991
-
$3.30 M(-760.0%)
$2.80 M(-660.0%)
Mar 1991
-$400.00 K(-73.3%)
-$500.00 K(<-9900.0%)
-$500.00 K(-94.3%)
Dec 1990
-
$0.00(0.0%)
-$8.80 M(+35.4%)
Sep 1990
-
$0.00(0.0%)
-$6.50 M(+51.2%)
Jun 1990
-
$0.00(-100.0%)
-$4.30 M(+152.9%)
Mar 1990
-$1.50 M(+66.7%)
-$8.80 M(-482.6%)
-$1.70 M(+112.5%)
Dec 1989
-
$2.30 M(+4.5%)
-$800.00 K(0.0%)
Sep 1989
-
$2.20 M(-15.4%)
-$800.00 K(0.0%)
Jun 1989
-
$2.60 M(-132.9%)
-$800.00 K(-27.3%)
Mar 1989
-$900.00 K(-400.0%)
-$7.90 M(-443.5%)
-$1.10 M(+83.3%)
Dec 1988
-
$2.30 M(+4.5%)
-$600.00 K(0.0%)
Sep 1988
-
$2.20 M(-4.3%)
-$600.00 K(+200.0%)
Jun 1988
-
$2.30 M(-131.1%)
-$200.00 K(-166.7%)
Mar 1988
$300.00 K(-40.0%)
-$7.40 M(-421.7%)
$300.00 K(-40.0%)
Dec 1987
-
$2.30 M(-11.5%)
$500.00 K(+25.0%)
Sep 1987
-
$2.60 M(-7.1%)
$400.00 K(-60.0%)
Jun 1987
-
$2.80 M(-138.9%)
$1.00 M(+233.3%)
Mar 1987
$500.00 K(0.0%)
-$7.20 M(-427.3%)
$300.00 K(>+9900.0%)
Dec 1986
-
$2.20 M(-31.3%)
$0.00(-100.0%)
Sep 1986
-
$3.20 M(+52.4%)
$500.00 K(-266.7%)
Jun 1986
-
$2.10 M(-128.0%)
-$300.00 K(-250.0%)
Mar 1986
$500.00 K(-120.8%)
-$7.50 M(-377.8%)
$200.00 K(-110.5%)
Dec 1985
-
$2.70 M(+12.5%)
-$1.90 M(-5.0%)
Sep 1985
-
$2.40 M(-7.7%)
-$2.00 M(-20.0%)
Jun 1985
-
$2.60 M(-127.1%)
-$2.50 M(-3.8%)
Mar 1985
-$2.40 M(-2500.0%)
-$9.60 M(-469.2%)
-$2.60 M(+333.3%)
Dec 1984
-
$2.60 M(+36.8%)
-$600.00 K(-81.3%)
Sep 1984
-
$1.90 M(-24.0%)
-$3.20 M(-37.3%)
Jun 1984
-
$2.50 M(-132.9%)
-$5.10 M(-32.9%)
Mar 1984
$100.00 K
-$7.60 M
-$7.60 M

FAQ

  • What is NextGen Healthcare annual EBITDA?
  • What is the all time high annual EBITDA for NextGen Healthcare?
  • What is NextGen Healthcare annual EBITDA year-on-year change?
  • What is NextGen Healthcare quarterly EBITDA?
  • What is the all time high quarterly EBITDA for NextGen Healthcare?
  • What is NextGen Healthcare quarterly EBITDA year-on-year change?
  • What is NextGen Healthcare TTM EBITDA?
  • What is the all time high TTM EBITDA for NextGen Healthcare?
  • What is NextGen Healthcare TTM EBITDA year-on-year change?

What is NextGen Healthcare annual EBITDA?

The current annual EBITDA of NXGN is $47.30 M

What is the all time high annual EBITDA for NextGen Healthcare?

NextGen Healthcare all-time high annual EBITDA is $134.15 M

What is NextGen Healthcare annual EBITDA year-on-year change?

Over the past year, NXGN annual EBITDA has changed by -$1.71 M (-3.50%)

What is NextGen Healthcare quarterly EBITDA?

The current quarterly EBITDA of NXGN is $19.32 M

What is the all time high quarterly EBITDA for NextGen Healthcare?

NextGen Healthcare all-time high quarterly EBITDA is $37.12 M

What is NextGen Healthcare quarterly EBITDA year-on-year change?

Over the past year, NXGN quarterly EBITDA has changed by -$9.14 M (-32.11%)

What is NextGen Healthcare TTM EBITDA?

The current TTM EBITDA of NXGN is $48.88 M

What is the all time high TTM EBITDA for NextGen Healthcare?

NextGen Healthcare all-time high TTM EBITDA is $138.15 M

What is NextGen Healthcare TTM EBITDA year-on-year change?

Over the past year, NXGN TTM EBITDA has changed by -$21.52 M (-30.57%)